Title : Clinical update: proteasome inhibitors in solid tumors.

Pub. Date : 2003 May

PMID : 12738242






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Bortezomib (VELCADE; formerly PS-341, LDP-341, MLN341) is a novel dipeptide boronic acid that is the first proteasome inhibitor to have progressed to clinical trials. Dipeptides carboxypeptidase Q Homo sapiens